We believe that strategic alliances and global collaborations can more efficiently commercialize innovations, enabling patients to receive better care.
Oncolys BioPharma Inc.

Oncolys BioPharma Inc.

Oncolys BioPharma Inc. is a publicly listed biopharmaceutical company in Japan, specializing in the development of oncolytic virus-based cancer therapies.  Since 2008, Medigen has formed a strategic alliance with Oncolys to jointly develop the anti-cancer drug OBP-301 and has conducted human clinical trials in Japan, Taiwan, and South Korea.

MEDINET Co., Ltd.

MEDINET Co., Ltd.

MEDINET Co., Ltd. is a publicly listed biotechnology company in Japan specializing in cell therapy. As a pioneer and leading company of cell-based products, MEDINET holds a broad portfolio of cell manufacturing technologies.  Since 2019, Medigen has partnered with MEDINET to collaborate on cell therapy in Taiwan.

NKure Therapeutics

NKure Therapeutics

NKure Therapeutics is a biotechnology company based in India, focused on developing innovative cell and gene therapy technologies to provide solutions for cancer and infectious diseases.  Starting in 2024, Medigen and NKure initiated a collaboration to advance the clinical application of Medigen's NK cell technology in the Indian market.

Medical and Clinical Institutions

Medical and Clinical Institutions


The following clinical institutions have collaborated with Medigen on clinical trials or cell therapy:

Taiwan:
National Taiwan University Hospital, Taipei Veterans General Hospital, Taichung Veterans General Hospital, Chang Gung Memorial Hospital, China Medical University Hospital, National Cheng Kung University Hospital, E-Da Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Tzu Chi Hospital, Show Chwan Memorial Hospital, Changhua Christian Hospital, Mackay Memorial Hospital, Chi Mei Hospital (Liouying), and Taipei Municipal Wanfang Hospital.

South Korea:
Yonsei University Severance Hospital, Gangnam Severance Hospital, Ajou University Hospital, Samsung Medical Center, Asan Medical Center, Seoul National University Hospital, Seoul St. Mary's Hospital, Korea University Guro Hospital, Pusan National University Hospital, Pusan National University Yangsan Hospital, and Kyungpook National University Hospital.

Hong Kong:
Queen Mary Hospital.

China:
Zhongshan Hospital, Fudan University (Shanghai), Union Medical College Hospital (Beijing), the PLA General Hospital (301 Hospital, Beijing), and the Third Xiangya Hospital of Central South University (Changsha).

Academic and Research Institutions

Academic and Research Institutions

The following academic and research institutions have collaborated with Medigen in industry–academia partnerships:

Academia Sinica, National Health Research Institutes (NHRI), Industrial Technology Research Institute (ITRI), Development Center for Biotechnology (DCB), National Taiwan University, National Yang Ming Chiao Tung University, and National Cheng Kung University.